Similar articles

• An overview of contemporary management of breast carcinoma.

  Suhrland LG. Suhrland LG. Obstet Gynecol Clin North Am. 1987 Sep;14(3):783-96. Obstet Gynecol Clin North Am. 1987. PMID: 3323974 Review.
• [Inflammatory cancer of the breast. Therapy and follow-up].

  Volz J, Volz E, Böhm W, Schneider V. Volz J, et al. Geburtshilfe Frauenheilkd. 1992 Apr;52(4):206-9. doi: 10.1055/s-2007-1026130. Geburtshilfe Frauenheilkd. 1992. PMID: 1607113 German.
• Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemma.

  Dizdar O, Arslan C, Altundag K. Dizdar O, et al. Clin Oncol (R Coll Radiol). 2010 Mar;22(2):153-4. doi: 10.1016/j.clon.2009.09.025. Epub 2009 Oct 27. Clin Oncol (R Coll Radiol). 2010. PMID: 19864120 No abstract available.
• [Effect of the proliferation rate on the course of node negative breast carcinoma].

  Mitze M, Weikel W, Brumm C, Lippold R, Knapstein PG. Mitze M, et al. Geburtshilfe Frauenheilkd. 1995 Jun;55(6):299-305. doi: 10.1055/s-2007-1023323. Geburtshilfe Frauenheilkd. 1995. PMID: 7657137 German.
• Molecular biology of breast cancer: integration of cellular and molecular concepts into therapeutic strategies.

  Konstadoulakis MM, Bland KI. Konstadoulakis MM, et al. R I Med. 1995 Sep;78(9):257-60. R I Med. 1995. PMID: 7579722 Review. No abstract available.